PET with 18F-FDG has been increasingly applied, predominantly in the research setting, to
study drug effects and pulmonary biology and to monitor disease progression and treatment …

Millions of people are affected by respiratory diseases, leading to a significant health burden
globally. Because of the current insufficient knowledge of the underlying mechanisms that …

Background Fluorine-18-fluorodeoxyglucose (18 F-FDG) PET/computed tomography (CT) is
a reliable imaging modality for the diagnosis of malignant lung nodules and to assess the …

Radiomics analysis quantifies the interpolation of multiple and invisible molecular features
present in diagnostic and therapeutic images. Implementation of 18-fluorine …

PET has seen rapid progression in recent years, with applications in oncology leading the
way. The glucose analog 18F-FDG is the most commonly used PET radiopharmaceutical …

Positron emission tomography (PET) combined with computed tomography (CT) is an
established diagnostic modality that has become an essential imaging tool in oncological …

Granulomatous lung diseases False-positive results with 18F-FDG-PET and PET-CT in the
setting of cancer have been mostly documented in granulomatous pulmonary diseases and …

Aim The aim of the study was to assess the prevalence of focal fluorine-18
fluorodeoxyglucose (18 F-FDG) activity in the lungs using 18 F-FDG PET/computed …

Objective The objective of this study was to assess suitability of dual-time-point 18 F-FDG
[(18 F)-fluoro-2-deoxyglucose]-PET imaging for differentiating between malignant and …

PET/CT with the tracer 2-[18 F] fluoro-2-deoxy-D-glucose ([18 F] FDG) has improved
diagnostic imaging in cancer and is routinely used for diagnosing, staging and treatment …